Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.
D000768:Anesthesia, General; D002675:Child, Preschool; D003620:Dantrolene / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007442:Intubation, Intratracheal; D008305:Malignant Hyperthermia / Q000517:prevention & control*; D009132:Muscles / Q000187:drug effects*; D010510:Periodontal Diseases / Q000601:surgery; D011292:Premedication; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D003620:Dantrolene